Fund Holdings

TAKEDA PHARMACEUTICAL CO LTD

Filing Period:
Securities
SharesValue ($K)
Q2 2025
Q3 2025
Change
Q2 2025
Q3 2025
Weight (%)
Change
Ovid Therapeutics, Inc.7,531,9967,531,99602,485,3809,791,59559.82%+7,306,215
Equillium, Inc.1,824,9771,824,9770575,2332,609,71715.94%+2,034,484
Shattuck Labs, Inc.515,619515,6190408,2671,232,3297.53%+824,062
Lyell Immunopharma, Inc.41,16554,887+13,722363,906891,3655.45%+527,459
Xilio Therapeutics, Inc. (formerly Akrevia Therapeutics)1,475,1211,475,12101,002,9351,243,0847.59%+240,149
Standard Biotools, Inc.16,51516,515019,81821,4700.13%+1,652
Rani Therapeutics Holdings, Inc.203,190203,1900104,419101,5540.62%-2,865
Third Harmonic Bio, Inc.36,8350-36,835200,0140-200,014
American Well Corporation77,73377,7330691,050478,0612.92%-212,989
Turnstone Biologics895,8240-895,824321,6010-321,601
HilleVax, Inc.6,724,0000-6,724,00013,381,1600-13,381,160
Page 1 of 1